IN2013MU01155A - - Google Patents

Info

Publication number
IN2013MU01155A
IN2013MU01155A IN1155MU2013A IN2013MU01155A IN 2013MU01155 A IN2013MU01155 A IN 2013MU01155A IN 1155MU2013 A IN1155MU2013 A IN 1155MU2013A IN 2013MU01155 A IN2013MU01155 A IN 2013MU01155A
Authority
IN
India
Prior art keywords
cyclobenzaprine
salts
composition
pharmaceutical compositions
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Vivek Dubey
Vishal Omprakash Daga
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060055 priority Critical patent/WO2014167440A1/en
Priority to IN1155MU2013 priority patent/IN2013MU01155A/en
Publication of IN2013MU01155A publication Critical patent/IN2013MU01155A/en

Links

IN1155MU2013 2013-03-26 2014-03-22 IN2013MU01155A (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/060055 WO2014167440A1 (en) 2013-03-26 2014-03-22 Modified release pharmaceutical compositions of cyclobenzaprine or salts thereof
IN1155MU2013 IN2013MU01155A (ru) 2013-03-26 2014-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1155MU2013 IN2013MU01155A (ru) 2013-03-26 2014-03-22

Publications (1)

Publication Number Publication Date
IN2013MU01155A true IN2013MU01155A (ru) 2015-04-24

Family

ID=54395429

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1155MU2013 IN2013MU01155A (ru) 2013-03-26 2014-03-22

Country Status (1)

Country Link
IN (1) IN2013MU01155A (ru)

Similar Documents

Publication Publication Date Title
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
IN2015DN03219A (ru)
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2015000485A (es) Tratamiento de esclerosis multiple con una combinacion de laquinimod y fampridina.
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
TW201129361A (en) Methods for treating pain
GB201115977D0 (en) Neurodevelopmental disorders
IN2013MU01155A (ru)
MX2016001177A (es) Tratamiento de esclerosis multiple con la combinacion de laquinimod y flupirtina.
MX2020005438A (es) Formas de dosificacion de sulfato de morfina disuasivas del abuso.
IN2013MU01154A (ru)
MX2014011843A (es) Compuestos para usarse en el tratamiento de neuroblastoma, sarcoma de ewing o rabdomiosarcoma.
IN2014MU01185A (ru)
IN2014MU01184A (ru)
SG10201809280PA (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
IN2013MU01245A (ru)
IN2013MU01246A (ru)
IN2013MU01250A (ru)
IN2013MU01247A (ru)